Medium-term Immunogenicity of Three Doses of BNT162b2 and CoronaVac in Hong Kong Neuromuscular Disease Patients
HUMAN VACCINES & IMMUNOTHERAPEUTICS（2024）
Key words
BNT162b2,COVID-19,CoronaVac,neuromuscular diseases,immunogenicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined